A share price of Qiagen NV [QGEN] is currently trading at $42.34, up 1.90%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The QGEN shares have gain 1.29% over the last week, with a monthly amount glided 1.07%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Qiagen NV [NYSE: QGEN] stock has seen the most recent analyst activity on June 27, 2024, when Wolfe Research upgraded its rating to a Outperform but kept the price target unchanged to $50 for it. Previously, Wells Fargo started tracking the stock with Equal Weight rating on December 19, 2023, and set its price target to $44. On December 13, 2023, Wolfe Research initiated with a Peer Perform rating. Goldman upgraded its rating to a Buy but stick to its price target of $50 on December 07, 2023. Robert W. Baird initiated its recommendation with a Outperform and recommended $50 as its price target on September 12, 2023. Morgan Stanley upgraded its rating to Overweight for this stock on May 23, 2023. In a note dated October 18, 2022, Morgan Stanley initiated an Equal-Weight rating.
Qiagen NV experienced fluctuations in its stock price throughout the past year between $34.74 and $47.69. Currently, Wall Street analysts expect the stock to reach $52.37 within the next 12 months. Qiagen NV [NYSE: QGEN] shares were valued at $42.34 at the most recent close of the market. An investor can expect a potential return of 23.69% based on the average QGEN price forecast.
Analyzing the QGEN fundamentals
Trailing Twelve Months sales for Qiagen NV [NYSE:QGEN] were 1.94B which represents -5.48% decline. Gross Profit Margin for this corporation currently stands at 0.64% with Operating Profit Margin at 0.22%, Pretax Profit Margin comes in at 0.22%, and Net Profit Margin reading is 0.17%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.09 and Total Capital is 0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.42.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 41.87 points at the first support level, and at 41.41 for the second support level. However, for the 1st resistance point, the stock is sitting at 42.60, and for the 2nd resistance point, it is at 42.87.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Qiagen NV [NYSE:QGEN] is 1.84. Also, the Quick Ratio is 1.45, while the Cash Ratio stands at 0.5. Considering the valuation of this stock, the price to sales ratio is 4.85, the price to book ratio is 2.63 and price to earnings (TTM) ratio is 28.20.
